|Bid||10.15 x 3000|
|Ask||10.20 x 1200|
|Day's Range||10.18 - 10.86|
|52 Week Range||6.87 - 18.94|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jan 27, 2010|
|1y Target Est||19.17|
Subscribe to Yahoo Finance Plus to view Fair Value for AXGN
The consensus price target hints at an 89.4% upside potential for AxoGen (AXGN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here is how Acadia Healthcare (ACHC) and AxoGen (AXGN) have performed compared to their sector so far this year.
AxoGen (AXGN) delivered earnings and revenue surprises of 60% and 5.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?